[Evaluation of the bronchospasmolytic activity of alupent and ipradol].
作者信息
Makel'skiĭ V V, Iartsev S S
出版信息
Sov Med. 1974 Sep;0(9):142-3.
PMID:4409508
Abstract
摘要
相似文献
1
[Evaluation of the bronchospasmolytic activity of alupent and ipradol].
Sov Med. 1974 Sep;0(9):142-3.
2
Metaproterenol, a new bronchodilator:: comparison with isoproterenol.间羟异丙肾上腺素，一种新型支气管扩张剂：与异丙肾上腺素的比较。
Am J Med Sci. 1967 Mar;253(3):321-4.
3
4
[Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
Wien Med Wochenschr. 1971 May 29;121(22):455-7.
5
Hexoprenaline--a new bronchodilator.
S Afr Med J. 1972 Dec 23;46(51):1999-2001.
6
[Observations on the use of a sympathomimetic aerosol for diagnostic and therapeutic use].[关于拟交感神经气雾剂用于诊断和治疗的观察]
Clin Ter. 1967 Dec 31;43(6):559-65.
7
[A new bronchospasmolytic].
Arzneimittelforschung. 1972 Jul;22(7):1223-5.
8
[Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
Pol Tyg Lek. 1975 Feb 17;30(7):301-4.
9
[Results of a clinical trial of a newly developped bronchospasmolytic agent (hexoprenalin, Ipradol)].[一种新开发的支气管解痉剂（海索那林、异丙苯戊酯）的临床试验结果]
Wien Klin Wochenschr. 1971 Feb 19;83(7):114-7.
10
[Treatment of spastic bronchitis with a new bronchospasmolytic agent].
Wien Med Wochenschr. 1972 Oct 14;122(42):606-9.
Zotero 插件